Celltinib 400 mg Tablet
Celltinib 400 mg Tablet is a prescription medicine used in the treatment of non-small cell lung cancer (NSCLC). It works by blocking abnormal proteins that trigger the growth and spread of cancer cells, thereby helping to stop or slow down the disease progression.
Celltinib 400 mg Tablet belongs to a class of medicines known as tyrosine kinase inhibitors (TKIs). It is primarily prescribed for patients with non-small cell lung cancer (NSCLC) that has specific epidermal growth factor receptor (EGFR) mutations. By selectively targeting and inhibiting the EGFR protein, Celltinib prevents cancer cells from multiplying and spreading, while minimally affecting normal cells.
This medicine should be taken exactly as directed by a healthcare professional, usually once daily, with or without food. The dosage may vary depending on the patient’s condition, genetic test results, and overall health.
Common side effects may include skin rash, diarrhea, nausea, loss of appetite, and weakness. In rare cases, it may cause serious lung, liver, or eye-related issues. Regular monitoring and follow-up with the doctor are important during treatment.
Celltinib 400 mg Tablet provides a targeted approach to cancer therapy, offering better outcomes and improved quality of life for eligible patients with advanced lung cancer.
Quantity |
---|
Reviews
There are no reviews yet.